SPY326.54-3.44 -1.04%
DIA265.06-1.53 -0.57%
IXIC10,911.59-274.00 -2.45%

Aytu BioScience Q4 EPS $(0.03), Inline, Sales $14.90M Beat $11.24M Estimate

Aytu BioScience (NASDAQ:AYTU) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 97.69 percent increase over losses of $(1.30) per share from the same period last year.

· 10/06/2020 16:03
Aytu BioScience (NASDAQ:AYTU) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 97.69 percent increase over losses of $(1.30) per share from the same period last year. The company reported quarterly sales of $14.90 million which beat the analyst consensus estimate of $11.24 million by 32.56 percent. This is a 768.30 percent increase over sales of $1.72 million the same period last year.